首页 > 最新文献

Acta Oncologica Turcica最新文献

英文 中文
Parosteal Osteosarcoma: Radiologic and Prognostic Features 骨旁骨肉瘤:放射学和预后特征
Pub Date : 1900-01-01 DOI: 10.5505/aot.2021.73549
O. Aycan, Muhammet Alptekin Kocaoğlu, M. Arslan, M. Mert, Alper Köksal
Aim: The aim of this study is to evaluate significance of Magnetic Resonance Imaging (MRI) characteristics and their effects on surgical margins, prognosis, oncological and functional outcomes of parosteal osteosarcoma in our clinic. Patients and method: Fifteen patients (4 male/11 female) who operated with the diagnosis of parosteal osteosarcoma in our clinic were retrospectively reviewed. The epidemiological data, biopsy method and delay in diagnosis are noted. The lesions maximum circumferential extension, intramedullary involvement and neurovascular extension in MRI sections were evaluated. The resection type (segmental articular/hemicortical) and surgical margins were noted. Functional and oncological results at last follow-up were assessed. Results: The mean age was 31.7 (17-71) years; mean follow-up was 50.1 (24-176) months. The most common site was distal femur. The closed biopsies were related with increased number of re-biopsies and misdiagnosis/improper interventions. (p<0.001,p=0.023) Intramedullary involvement percentage was related with maximum circumferential extension percentage (p=0.006) The intramedullary involvement ratio of ≤25% suggested no recurrence or metastasis. The mean MSTS score was 87.8% (range, 60-100%). The neurovascular involvement was related with metastatic disease, deep infections and complication related surgeries. (p=0.017, p=0.002,p=0.005) The most common resection type was segmental articular resection (9 patients). Hemicortical resections with biological reconstructions had the best MSTS scores. (p=0.002) The maximum circumferential extension percentage, intramedullary involvement percentage and neurovascular involvement showed lower MSTS scores. The 5-year overall survival was 92.3%, local recurrence-free survival was 86.2% and metastasis-free survival was 86.2%. Conclusion: The reliability of needle biopsy sampling is controversial in parosteal osteosarcomas. The lesions extent of intramedullary involvement, neurovascular bundle proximity and maximum periosteal circumferential extension on MRI should be considered when planning the surgery. The evaluation of maximum circumferential extension on MRI is crucial for the resection margins.
{"title":"Parosteal Osteosarcoma: Radiologic and Prognostic Features","authors":"O. Aycan, Muhammet Alptekin Kocaoğlu, M. Arslan, M. Mert, Alper Köksal","doi":"10.5505/aot.2021.73549","DOIUrl":"https://doi.org/10.5505/aot.2021.73549","url":null,"abstract":"Aim: The aim of this study is to evaluate significance of Magnetic Resonance Imaging (MRI) characteristics and their effects on surgical margins, prognosis, oncological and functional outcomes of parosteal osteosarcoma in our clinic. Patients and method: Fifteen patients (4 male/11 female) who operated with the diagnosis of parosteal osteosarcoma in our clinic were retrospectively reviewed. The epidemiological data, biopsy method and delay in diagnosis are noted. The lesions maximum circumferential extension, intramedullary involvement and neurovascular extension in MRI sections were evaluated. The resection type (segmental articular/hemicortical) and surgical margins were noted. Functional and oncological results at last follow-up were assessed. Results: The mean age was 31.7 (17-71) years; mean follow-up was 50.1 (24-176) months. The most common site was distal femur. The closed biopsies were related with increased number of re-biopsies and misdiagnosis/improper interventions. (p<0.001,p=0.023) Intramedullary involvement percentage was related with maximum circumferential extension percentage (p=0.006) The intramedullary involvement ratio of ≤25% suggested no recurrence or metastasis. The mean MSTS score was 87.8% (range, 60-100%). The neurovascular involvement was related with metastatic disease, deep infections and complication related surgeries. (p=0.017, p=0.002,p=0.005) The most common resection type was segmental articular resection (9 patients). Hemicortical resections with biological reconstructions had the best MSTS scores. (p=0.002) The maximum circumferential extension percentage, intramedullary involvement percentage and neurovascular involvement showed lower MSTS scores. The 5-year overall survival was 92.3%, local recurrence-free survival was 86.2% and metastasis-free survival was 86.2%. Conclusion: The reliability of needle biopsy sampling is controversial in parosteal osteosarcomas. The lesions extent of intramedullary involvement, neurovascular bundle proximity and maximum periosteal circumferential extension on MRI should be considered when planning the surgery. The evaluation of maximum circumferential extension on MRI is crucial for the resection margins.","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115940551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison the Clinical Features of Newly Diagnosed Multiple Myeloma Patients According to CD23 Expression Status CD23表达水平对新发多发性骨髓瘤患者临床特征的影响
Pub Date : 1900-01-01 DOI: 10.5505/aot.2022.13008
U. Iltar, O. Salim, T. Ulaş, S. Berker Karaüzüm, C. Aydin, L. Undar
{"title":"Comparison the Clinical Features of Newly Diagnosed Multiple Myeloma Patients According to CD23 Expression Status","authors":"U. Iltar, O. Salim, T. Ulaş, S. Berker Karaüzüm, C. Aydin, L. Undar","doi":"10.5505/aot.2022.13008","DOIUrl":"https://doi.org/10.5505/aot.2022.13008","url":null,"abstract":"","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"384 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115989781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Standart Prophylactic Granulocyte Colony Stimulating Factor Usage As A Part Of Autologous Stem Cell Transplantati̇on Procedure 自体干细胞移植过程中预防性粒细胞集落刺激因子的标准应用
Pub Date : 1900-01-01 DOI: 10.5505/aot.2022.47113
Lale Aydın Kaynar, Z. N. Özkurt, F. Can, Z. Yeğin, Özlem Güzel Tunçcan, M. Yağcı
{"title":"Standart Prophylactic Granulocyte Colony Stimulating Factor Usage As A Part Of Autologous Stem Cell Transplantati̇on Procedure","authors":"Lale Aydın Kaynar, Z. N. Özkurt, F. Can, Z. Yeğin, Özlem Güzel Tunçcan, M. Yağcı","doi":"10.5505/aot.2022.47113","DOIUrl":"https://doi.org/10.5505/aot.2022.47113","url":null,"abstract":"","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116669488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Optimal Treatment Approaches and Prognostic Factors In Elderly Patients with Advanced Stage Biliary Tract Tumors 老年晚期胆道肿瘤患者的最佳治疗方法及影响预后的因素
Pub Date : 1900-01-01 DOI: 10.5505/aot.2023.03708
Sabin Göktaş Aydın, Burçin Çakan Demirel, A. Bilici, C. Yilmaz, A. Topçu, M. Aykan, S. Kahraman, M. Atçı, I. Akbıyık, Fahri Akgül, Ö. Ölmez, A. Aydin
{"title":"The Optimal Treatment Approaches and Prognostic Factors In Elderly Patients with Advanced Stage Biliary Tract Tumors","authors":"Sabin Göktaş Aydın, Burçin Çakan Demirel, A. Bilici, C. Yilmaz, A. Topçu, M. Aykan, S. Kahraman, M. Atçı, I. Akbıyık, Fahri Akgül, Ö. Ölmez, A. Aydin","doi":"10.5505/aot.2023.03708","DOIUrl":"https://doi.org/10.5505/aot.2023.03708","url":null,"abstract":"","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"1121 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116072966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
False-positive MRI Findings in Breast Cancer After Neoadjuvant Chemotherapy and Correlation Between Tumor Response Patterns and HER2 Status 乳腺癌新辅助化疗后MRI假阳性表现及肿瘤反应模式与HER2状态的相关性
Pub Date : 1900-01-01 DOI: 10.5505/aot.2023.60973
Aydan Avdan Aslan, Servet Erdemli, I. Erdogdu, Serap Gültekin, C. Uras, F. Tokat, A. Arıcan, Leyla Özer, Kemal Behzatoğlu, N. Meydan, F. Taşkın
{"title":"False-positive MRI Findings in Breast Cancer After Neoadjuvant Chemotherapy and Correlation Between Tumor Response Patterns and HER2 Status","authors":"Aydan Avdan Aslan, Servet Erdemli, I. Erdogdu, Serap Gültekin, C. Uras, F. Tokat, A. Arıcan, Leyla Özer, Kemal Behzatoğlu, N. Meydan, F. Taşkın","doi":"10.5505/aot.2023.60973","DOIUrl":"https://doi.org/10.5505/aot.2023.60973","url":null,"abstract":"","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126752425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are platelet and eosinophil parameters indicators of predicting the development of erectile dysfunction after radical prostatectomy? 血小板和嗜酸性粒细胞参数是预测根治性前列腺切除术后勃起功能障碍的指标吗?
Pub Date : 1900-01-01 DOI: 10.5505/AOT.2019.75436
I. Selvi, E. Öztürk
INTRODUCTION: Erectile dysfunction(ED) may develop in 14-90% following radical prostatectomy(RP). Development of ED is due to neurovascular damage during surgery. In our study, we aimed to evaluate whether the platelet and eosinophil parameters are prognostic factors in predicting ED after prostatectomy. METHODS: Data of 181 patients who underwent RP between January 2010 and December 2016 were analyzed retrospectively. In the preoperative period, platelet count, mean platelet volume (MPV), platelet distribution width (PDW) and eosinophil count were recorded. The patients were evaluated for ED according to the International Erectile Function Index in preoperatively and postoperatively. In the postoperative 12th month, ED was observed in 128 patients following RP. Among them, 82 patients with postoperative ED were included in Group I, and 46 patients without postoperative ED were included in Group II. RESULTS: Age (p=0.281) and body mass index (p=0.851) had no significant difference between groups. In preoperative period, mean platelet count (292.18±51.62 vs. 240.15±46.25, p<0.001), mean MPV value (8.77±1.24 vs. 6.17±0.87, p<0.001) and mean eosinophil count (0.57±0.16 vs. 0.47±0.10, p<0.001) were higher Orijinal Çalışma 137 Adress for correspondence: İsmail Selvi, Karabük Üniversitesi Eğitim ve Araştırma Hastanesi, Üroloji Kliniği 78200 Merkez / Karabük – Türkiye e-mail: ismselvi33@hotmail.com Available at www.actaoncologicaturcica.com Copyright ©Ankara Onkoloji Hastanesi in Group I. Mean PDW value (16.21±1.84 vs.16.75±1.77, p=0.110) had no significantly difference. According to ROC analysis, the cut-off values for platelet, MPV and eosinophil were 242 (AUC: 0.783, p<0.001), 7.24 (AUC: 0.951, p<0.001) and 0.5 (AUC: 0.675, p=0.001), respectively. In multivariate analysis, MPV and eosinophil were found to be more important independent factors in predicting ED after RP. DISCUSSION and CONCLUSION: It is shown that platelet, MPV and eosinophil are independent predictive factors in predicting ED following prostatectomy.
导言:14-90%的根治性前列腺切除术(RP)后可能出现勃起功能障碍(ED)。ED的发展是由于手术过程中神经血管的损伤。在我们的研究中,我们旨在评估血小板和嗜酸性粒细胞参数是否是预测前列腺切除术后ED的预后因素。方法:回顾性分析2010年1月至2016年12月181例RP患者的资料。术前记录血小板计数、平均血小板体积(MPV)、血小板分布宽度(PDW)和嗜酸性粒细胞计数。术前和术后根据国际勃起功能指数对患者进行ED评价。术后12个月,128例RP患者出现ED。其中,有术后ED的患者82例作为第一组,无术后ED的患者46例作为第二组。结果:年龄(p=0.281)、体重指数(p=0.851)组间差异无统计学意义。术前平均血小板计数(292.18±51.62比240.15±46.25,p<0.001)、平均MPV值(8.77±1.24比6.17±0.87,p<0.001)、平均酸性粒细胞计数(0.57±0.16比0.47±0.10,p<0.001)较高。原始Çalışma 137通讯地址:İsmail Selvi, karab Üniversitesi Eğitim ve Araştırma Hastanesi, Üroloji Kliniği 78200 Merkez / karab k - t rkiyeismselvi33@hotmail.com见www.actaoncologicaturcica.com版权©Ankara Onkoloji Hastanesi第一组平均PDW值(16.21±1.84 vs.16.75±1.77,p=0.110)无显著差异。根据ROC分析,血小板、MPV和嗜酸性粒细胞的截止值分别为242 (AUC: 0.783, p<0.001)、7.24 (AUC: 0.951, p<0.001)和0.5 (AUC: 0.675, p=0.001)。在多因素分析中,MPV和嗜酸性粒细胞是预测RP后ED更重要的独立因素。讨论与结论:血小板、MPV和嗜酸性粒细胞是预测前列腺切除术后ED的独立预测因素。
{"title":"Are platelet and eosinophil parameters indicators of predicting the development of erectile dysfunction after radical prostatectomy?","authors":"I. Selvi, E. Öztürk","doi":"10.5505/AOT.2019.75436","DOIUrl":"https://doi.org/10.5505/AOT.2019.75436","url":null,"abstract":"INTRODUCTION: Erectile dysfunction(ED) may develop in 14-90% following radical prostatectomy(RP). Development of ED is due to neurovascular damage during surgery. In our study, we aimed to evaluate whether the platelet and eosinophil parameters are prognostic factors in predicting ED after prostatectomy. METHODS: Data of 181 patients who underwent RP between January 2010 and December 2016 were analyzed retrospectively. In the preoperative period, platelet count, mean platelet volume (MPV), platelet distribution width (PDW) and eosinophil count were recorded. The patients were evaluated for ED according to the International Erectile Function Index in preoperatively and postoperatively. In the postoperative 12th month, ED was observed in 128 patients following RP. Among them, 82 patients with postoperative ED were included in Group I, and 46 patients without postoperative ED were included in Group II. RESULTS: Age (p=0.281) and body mass index (p=0.851) had no significant difference between groups. In preoperative period, mean platelet count (292.18±51.62 vs. 240.15±46.25, p<0.001), mean MPV value (8.77±1.24 vs. 6.17±0.87, p<0.001) and mean eosinophil count (0.57±0.16 vs. 0.47±0.10, p<0.001) were higher Orijinal Çalışma 137 Adress for correspondence: İsmail Selvi, Karabük Üniversitesi Eğitim ve Araştırma Hastanesi, Üroloji Kliniği 78200 Merkez / Karabük – Türkiye e-mail: ismselvi33@hotmail.com Available at www.actaoncologicaturcica.com Copyright ©Ankara Onkoloji Hastanesi in Group I. Mean PDW value (16.21±1.84 vs.16.75±1.77, p=0.110) had no significantly difference. According to ROC analysis, the cut-off values for platelet, MPV and eosinophil were 242 (AUC: 0.783, p<0.001), 7.24 (AUC: 0.951, p<0.001) and 0.5 (AUC: 0.675, p=0.001), respectively. In multivariate analysis, MPV and eosinophil were found to be more important independent factors in predicting ED after RP. DISCUSSION and CONCLUSION: It is shown that platelet, MPV and eosinophil are independent predictive factors in predicting ED following prostatectomy.","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128184949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asymmetric tonsil hypertrophy may be a sign of Burkitt’s lymphoma 不对称扁桃体肥大可能是伯基特淋巴瘤的征兆
Pub Date : 1900-01-01 DOI: 10.5505/AOT.2019.47550
S. Aydın, E. Boldaz
A 4-year-old boy has had cryptic membranous tonsillitis episode 5-6 times since last year and applied to our Ear Nose and Throat (ENT) clinic for the last 3 months of onset of odynophagia. Patient showed asymmetric hypertrophy of the left tonsil (grade 4) and the appearance of ulcerated surface was observed (Figure 1). In computerized tomography; (sections crossing oropharynx levels) it was interpreted as a mass that could be malignant in the soft tissue density of the contour of the left parapharyngeal lesion of approximately 41x31 mm. Tonsillectomy was performed with general anesthesia. Histopathologic and immunohistochemical findings were compatible with Burkitt's lymphoma (BL), CD20 (+) and Ki67 proliferation index were 90% positive (Figure 2). The patient was referred to the oncology clinic for chemotherapy.
一名4岁男孩自去年以来5-6次隐蔽性膜性扁桃体炎发作,并在最近3个月出现咽痛时到我耳鼻喉科就诊。患者表现为左侧扁桃体不对称肥大(4级),并观察到溃疡表面的外观(图1)。(横过口咽部的切片)左侧咽旁病变轮廓的软组织密度约为41x31 mm,解释为可能是恶性肿块。全麻下行扁桃体切除术。组织病理学和免疫组织化学检查结果与伯基特淋巴瘤(BL)相符,CD20(+)和Ki67增殖指数90%阳性(图2)。患者转诊至肿瘤诊所进行化疗。
{"title":"Asymmetric tonsil hypertrophy may be a sign of Burkitt’s lymphoma","authors":"S. Aydın, E. Boldaz","doi":"10.5505/AOT.2019.47550","DOIUrl":"https://doi.org/10.5505/AOT.2019.47550","url":null,"abstract":"A 4-year-old boy has had cryptic membranous tonsillitis episode 5-6 times since last year and applied to our Ear Nose and Throat (ENT) clinic for the last 3 months of onset of odynophagia. Patient showed asymmetric hypertrophy of the left tonsil (grade 4) and the appearance of ulcerated surface was observed (Figure 1). In computerized tomography; (sections crossing oropharynx levels) it was interpreted as a mass that could be malignant in the soft tissue density of the contour of the left parapharyngeal lesion of approximately 41x31 mm. Tonsillectomy was performed with general anesthesia. Histopathologic and immunohistochemical findings were compatible with Burkitt's lymphoma (BL), CD20 (+) and Ki67 proliferation index were 90% positive (Figure 2). The patient was referred to the oncology clinic for chemotherapy.","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"106 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124929690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective analysis of patients diagnosed with multiple myeloma: A single center experience 多发性骨髓瘤患者的回顾性分析:单中心经验
Pub Date : 1900-01-01 DOI: 10.5505/aot.2019.24582
M. Şimşek, P. Tarkun, A. Hacıhanefioğlu
{"title":"Retrospective analysis of patients diagnosed with multiple myeloma: A single center experience","authors":"M. Şimşek, P. Tarkun, A. Hacıhanefioğlu","doi":"10.5505/aot.2019.24582","DOIUrl":"https://doi.org/10.5505/aot.2019.24582","url":null,"abstract":"","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"2012 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121751245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of Adjuvant Intravesical Mitomycin-C Treatment in Non-Muscle Invaziv High-Grade Bladder Cancer: Singe center experience 膀胱内辅助丝裂霉素c治疗非肌肉浸润性高级别膀胱癌的结果:单中心经验
Pub Date : 1900-01-01 DOI: 10.5505/aot.2019.50479
O. U. Cakici, N. Hamidi
INTRODUCTION: The aim of the present study is to evaluate and report the clinical efficiacy of adjuvant intravesical mitomycin-c in the treatment of non-muscle invaziv high-grade bladder cancer patients of a tertiary single health-care center. MATERIAL and METHODS: Electronic records of the patients who had undergone endoscopic treatment of bladder tumors between Jan 2012 and Dec 2018 are retrospectively reviewed. Data of the patients who were diagnosed with non-invasive high-grade urothelial carcinoma are further evaluated if adjuvant intravesical mitomycin-c therapy had been initiated and included in the study. Patient demographics, cystoscopy findings, pathological findings, and outpatients record are included in the analysis. RESULTS: Total of 54 patients included in this study. Among them 50 patients had pT1 disease while 4 patients had pTa disease. None of the patients in this cohort had carcinoma-in-situ. Mean tumor diameter was 1.4 cm. Mean time from initial transurethral resection to the application of the adjuvant therapy was 2 weeks (1-4 weeks). Mean follow-up time was 21 months. During the follow-up, tumor progression was observed in 14 (26%) patients, high-grade tumor recurrence was observed in 22 (41%) patients, and low-grade tumor recurrence was observed in 4 (7%) patients. Among the 22 patients who had high-grade recurrence, 6 patients had also tumor progression during the follow-up Orijinal Çalışma 156 Adress for correspondence: Özer Ural Çakıcı, Yenimahalle Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, Ankara Türkiye e-mail: ozerural@hotmail.com Available at www.actaoncologicaturcica.com Copyright ©Ankara Onkoloji Hastanesi DISCUSSION AND CONCLUSION: Non-invasive high-grade bladder cancer holds significant risk of stage progression and recurrence. The contemporary clinical guidelines endorse adjuvant intravesical BCG treatment in the management of non-muscle invasive bladder cancer. Due to our results, adjuvant intravesical mitomycin-c therapy can be considered as a accomplished alternative.
简介:本研究的目的是评估和报告辅助膀胱内丝裂霉素治疗非肌肉侵袭性高级别膀胱癌患者的临床疗效。材料和方法:回顾性分析2012年1月至2018年12月膀胱肿瘤内镜治疗患者的电子记录。对于诊断为非侵袭性高级别尿路上皮癌的患者数据,如果已经开始并纳入研究,则进一步评估辅助膀胱内丝裂霉素治疗。患者人口统计学、膀胱镜检查结果、病理结果和门诊记录都包括在分析中。结果:本研究共纳入54例患者。其中pT1病变50例,pTa病变4例。该队列中没有患者患有原位癌。平均肿瘤直径1.4 cm。从最初经尿道切除到应用辅助治疗的平均时间为2周(1-4周)。平均随访时间21个月。随访期间,14例(26%)患者出现肿瘤进展,22例(41%)患者出现高级别肿瘤复发,4例(7%)患者出现低级别肿瘤复发。在22例高级别复发患者中,6例患者在随访期间也出现肿瘤进展原件Çalışma 156通信地址:Özer Ural Çakıcı, Yenimahalle Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, Ankara t rkiye e-mail: ozerural@hotmail.com可在www.actaoncologicaturcica.com获取版权©Ankara Onkoloji Hastanesi讨论和结论:非侵袭性高级别膀胱癌具有显著的分期进展和复发风险。当代临床指南支持辅助膀胱内卡介苗治疗非肌肉浸润性膀胱癌。由于我们的结果,辅助膀胱内丝裂霉素治疗可以被认为是一个成功的选择。
{"title":"Outcomes of Adjuvant Intravesical Mitomycin-C Treatment in Non-Muscle Invaziv High-Grade Bladder Cancer: Singe center experience","authors":"O. U. Cakici, N. Hamidi","doi":"10.5505/aot.2019.50479","DOIUrl":"https://doi.org/10.5505/aot.2019.50479","url":null,"abstract":"INTRODUCTION: The aim of the present study is to evaluate and report the clinical efficiacy of adjuvant intravesical mitomycin-c in the treatment of non-muscle invaziv high-grade bladder cancer patients of a tertiary single health-care center. MATERIAL and METHODS: Electronic records of the patients who had undergone endoscopic treatment of bladder tumors between Jan 2012 and Dec 2018 are retrospectively reviewed. Data of the patients who were diagnosed with non-invasive high-grade urothelial carcinoma are further evaluated if adjuvant intravesical mitomycin-c therapy had been initiated and included in the study. Patient demographics, cystoscopy findings, pathological findings, and outpatients record are included in the analysis. RESULTS: Total of 54 patients included in this study. Among them 50 patients had pT1 disease while 4 patients had pTa disease. None of the patients in this cohort had carcinoma-in-situ. Mean tumor diameter was 1.4 cm. Mean time from initial transurethral resection to the application of the adjuvant therapy was 2 weeks (1-4 weeks). Mean follow-up time was 21 months. During the follow-up, tumor progression was observed in 14 (26%) patients, high-grade tumor recurrence was observed in 22 (41%) patients, and low-grade tumor recurrence was observed in 4 (7%) patients. Among the 22 patients who had high-grade recurrence, 6 patients had also tumor progression during the follow-up Orijinal Çalışma 156 Adress for correspondence: Özer Ural Çakıcı, Yenimahalle Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, Ankara Türkiye e-mail: ozerural@hotmail.com Available at www.actaoncologicaturcica.com Copyright ©Ankara Onkoloji Hastanesi DISCUSSION AND CONCLUSION: Non-invasive high-grade bladder cancer holds significant risk of stage progression and recurrence. The contemporary clinical guidelines endorse adjuvant intravesical BCG treatment in the management of non-muscle invasive bladder cancer. Due to our results, adjuvant intravesical mitomycin-c therapy can be considered as a accomplished alternative.","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131283628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prognostic impact of tumor budding in lung squamous cell carcinoma 肺鳞状细胞癌肿瘤出芽对预后的影响
Pub Date : 1900-01-01 DOI: 10.5505/aot.2019.76768
M. Tepeoğlu
{"title":"The prognostic impact of tumor budding in lung squamous cell carcinoma","authors":"M. Tepeoğlu","doi":"10.5505/aot.2019.76768","DOIUrl":"https://doi.org/10.5505/aot.2019.76768","url":null,"abstract":"","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"156 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116603944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Acta Oncologica Turcica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1